Elevated Plasma Homocysteine and Low Vitamin B-6 Status in Nonsupplementing Older Women with Rheumatoid Arthritis

Journal of the American Dietetic Association

Volumn 108, Issue 3, 2008, Pages 443-453

  Woolf, Kathleen ^a   Manore, Melinda M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPID; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; TRANSCOBALAMIN; VITAMIN B COMPLEX;

AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHEMISTRY; CROSS-SECTIONAL STUDY; ERYTHROCYTE; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MEDICAL RECORD; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PYRIDOXINE DEFICIENCY; RHEUMATOID ARTHRITIS; RISK FACTOR;

AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIET RECORDS; ERYTHROCYTES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIPIDS; MIDDLE AGED; NUTRITIONAL STATUS; PYRIDOXAL PHOSPHATE; RISK FACTORS; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 6; VITAMIN B 6 DEFICIENCY; VITAMIN B COMPLEX;

EID: 39649105655     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2007.12.001     Document Type: Article

References (73)

1. DeMaria A.N. Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol 89 suppl 6A (2002) 33D-38D
2. Mikuls T.R., and Saag K.G. Comorbidity in rheumatoid arthritis. Rheum Dis Clin North Am 27 (2001) 283-303
3. Snow M.H., and Mikuls T.R. Rheumatoid arthritis and cardiovascular disease: The role of systemic inflammation and evolving strategies of prevention. Curr Opin Rheumatol 17 (2005) 234-241
4. del Rincon I., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44 (2001) 2737-2745
5. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 14 (2002) 115-120
6. Lazarevic M.B., Vitic J., Mladenovic V., Myones B.L., Skosey J.L., and Swedler W.I. Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 22 (1992) 172-180
7. 2 to this atherogenic profile. Arthritis Rheum 44 (2001) 2761-2767
8. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 342 (2000) 836-843
9. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Eng J Med 340 (1999) 448-454
10. Jacobsson L.T.H., Turesson C., Hanson R.L., Pillemer S., Sievers M.L., Pettitt D.J., Bennett P.H., and Knowler W.C. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians. Arthritis Rheum 44 (2001) 1170-1176
11. Manzi S., and Wasko M.C.M. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59 (2000) 321-325
12. Solomon D.H., Curhan G.C., Rimm E.B., Cannuscio C.C., and Karlson E.W. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50 (2004) 3444-3449
13. Bostom A.G., Silbershatz H., Rosenberg I.H., Selhub J., D'Agostino R.B., Wolf P.A., Jacques P.F., and Wilson P.W.F. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159 (1999) 1077-1080
14. Boushey C.J., Beresford S.A.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 274 (1995) 1049-1057
15. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., and Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Eng J Med 324 (1991) 1149-1155
16. DeBree A., Verschuren W.M.M., Kromhout D., Kluijtmans L.A.J., and Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 54 (2002) 599-618
17. Mangoni A.A., and Jackson S.H.D. Homocysteine and cardiovascular disease: Current evidence and future prospects. Am J Med 112 (2002) 556-565
18. Ridker P.M., Manson J.E., Buring J.E., Shih J., Matias M., and Hennekens C.H. Homocysteine and risk of cardiovascular disease among postmenopausal women. J Am Med Assoc 281 (1999) 1817-1821
19. Stampfer M.J., Mallinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., Tishler P.V., and Hennekens C.H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 268 (1992) 877-881
20. Mayer E.L., Jacobsen D.W., and Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27 (1996) 517-527
21. Selhub J. Homocysteine metabolism. Annu Rev Nutr 19 (1999) 217-246
22. Ubbink J.B. Homocysteine-An atherogenic and a thrombogenic factor?. Nutr Rev 53 (1995) 323-325
23. Bates C.J., Pentieva K.D., Prentice A., Mansoor M.A., and Finch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr 81 (1999) 191-201
24. Morrison H.I., Schaubel D., Desmeules M., and Wigle D.T. Serum folate and risk of fatal coronary heart disease. J Am Med Assoc 275 (1996) 1893-1896
25. Pancharuniti N., Lewis C.A., Sauberlich H.E., Perkins L.L., Go R.C.P., Alvarez J.O., Macaluso M., Acton R.T., Copeland R.B., Cousins A.L., Gore T.B., Cornwell P.E., and Roseman J.M. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59 (1994) 940-948
26. Robinson K., Mayer E.L., Miller D.P., Green R., van Lente F., Gupta A., Kottke-Marchant K., Savon S.R., Selhub J., Nissen S.E., Kutner M., Topol E.J., and Jacobsen D.W. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 92 (1995) 2825-2830
27. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 270 (1993) 2693-2698
28. Fowler B. Homocysteine: Overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med 5 (2005) 77-86
29. Verhoef P., and de Groot L.C.P.G.M. Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med 5 (2005) 110-123
30. Brouwer I., van Dusseldorp M., Thomas C.M.G., Duran M., Hautvast J.G.A.J., Eskes T.K.A.B., and Steegers-Theunissen R.P.M. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomized trial. Am J Clin Nutr 69 (1999) 99-104
31. Clarke R., and Armitage J. Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26 (2000) 341-348
32. Koehler K.M., Romero L.J., Stauber P.M., Pareo-Tubbeh S.L., Liang H.C., Baumgartner R.N., Garry P.J., Allen R.H., and Stabler S.P. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 15 (1996) 364-376
33. McKinley M.C., McNulty H., McPartlin J., Strain J.J., Pentieva K., Ward M., Weir D.G., and Scott J.M. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73 (2001) 759-764
34. Rimm E.B., Willett W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., Hennekens C., and Stampfer M.J. Folate and vitamin B-6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 279 (1998) 359-364
35. Yxfeldt A., Wallberg-Jonsson S., Hultdin J., and Rantapaa-Dahlqvist S. Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 32 (2003) 205-210
36. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., and Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
37. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
38. Kang S.S., Wong P.W.K., Glickman P.B., MacLeod C.M., and Jaffe I.A. Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatment. J Clin Pharmacol 26 (1986) 712-715
39. Haagsma C.J., Blom H.J., van Riel P.L.C.M., van't Hof M.A., Giesendorf B.A.J., van Oppenraaij-Emmerzaal D., and van de Putte L.B.A. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58 (1999) 79-84
40. Hoekstra M., Haagsma C.J., Doelman C.J.A., and van de Laar M.A.F.J. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate. Ann Rheum Dis 64 (2005) 141-143
41. Slot O. Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid. Scand J Rheumatol 30 (2001) 305-307
42. Hornung N., Ellingsen T., Stengaard-Pedersen K., and Poulsen J.H. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol 31 (2004) 2374-2381
43. Morgan S.L., Baggott J.E., Lee J.Y., and Alarcon G.S. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low-dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention. J Rheumatol 25 (1998) 441-446
44. van Ede A.E., Laan R.F.J.M., Blom H.J., Boers G.H.J., Haagsma C.J., Thomas C.M.G., de Boo T.M., and van de Putte L.B.A. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology 41 (2002) 658-665
45. Pettersson T., Friman C., Abrahamsson L., Nilsson B., and Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia. J Rheumatol 25 (1998) 859-863
46. Hernanz A., Plaza A., Martin-Mola E., and De Miguel E. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clin Biochem 32 (1999) 65-70
47. Roubenoff R., Dellaripa P., Nadeau M.R., Abad L.W., Muldoon B.A., Selhub J., and Rosenberg I.H. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40 (1997) 718-722
48. Seriolo B., Fasciolo D., Sulli A., and Cutolo M. Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: Relationships with thrombotic events. Clin Exp Rheumatol 19 (2001) 561-564
49. Cisternas M., Gutierrez M.A., Klaassen J., Acosta A.M., and Jacobelli S. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 29 (2002) 1619-1622
50. Lopez-Olivio M.A., Gonzalez-Lopez L., Garcia-Gonzalez A., Villa-Manzano A.I., Cota-Sanchez A.R., Salazar-Paramo M., Varon-Villalpando E., Cardona-Munoz E.G., and Gamez-Nava J.I. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35 (2006) 112-116
51. Chiang E.P.I., Bagley P.J., Roubenoff R., Nadeau M., and Selhub J. Plasma pyridoxal 5′ phosphate concentration is correlated with functional vitamin B-6 indexes in patients with rheumatoid arthritis and marginal vitamin B-6 status. J Nutr 133 (2003) 1056-1059
52. Chiang E.P.I., Bagley P.J., Selhub J., Nadeau M., and Roubenoff R. Abnormal vitamin B-6 status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 114 (2003) 283-287
53. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., Medsger T.A., Mitchell D.M., Neustadt D.H., Pinals R.S., Schaller J.G., Sharp J.T., Wilder R.L., and Hunder G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
54. Fries J.F., Spitz P., Kraines R.G., and Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
55. Ramey D.R., Fries J.F., and Singh G. The Health Assessment Questionnaire 1995-status and review. In: Spilker B. (Ed). Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. (1996), Lippincott-Raven, Philadelphia, PA 227-237
56. Herzlich B., and Herbert V. Depletion of serum holotranscobalamin II. An early sign of negative vitamin B-12 balance. Lab Invest 58 (1988) 332-337
57. Sampson D.A., and O'Connor D.K. Response of B-6 vitamers in plasma, erythrocytes and tissues to vitamin B-6 depletion and repletion in the rat. J Nutr 119 (1989) 1940-1948
58. Durand P., Fortin L.J., Lussier-Cacan S., Davignon J., and Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load-Applications of a modified HPLC method. Clin Chim Acta 252 (1996) 83-93
59. Jacobsen D.W., Gatautis V.J., Green R., Robinson K., Savon S.R., Secic M., Ji J., Otto J.M., and Taylor L.M. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 40 (1994) 873-881
60. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B-6, Folate, Vitamin B-12, Pantothenic Acid, Biotin, and Choline (1998), National Academies Press, Washington, DC
61. Selhub J., Jacques P.F., Rosenberg I.H., Rogers G., Bowman B.A., Gunter E.W., Wright J.D., and Johnson C.L. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131 (1999) 331-339
62. Gomez-Vaquero C., Nolla J.M., Fiter J., Ramon J.M., Concustell R., Valverde J., and Roig-Escofet D. Nutritional status in patients with rheumatoid arthritis. Joint Bone Spine 68 (2001) 403-409
63. Morgan S.L., Anderson A.M., Hood S.M., Matthews P.A., Lee J.Y., and Alarcon G.S. Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis. Arthritis Care Res 10 (1997) 9-17
64. US Department of Agriculture, Agricultural Research Service. Data tables: Results from USDA's 1994-96 Continuing Survey of Food Intakes by Individuals and 1994-96 Diet and Health Knowledge Survey. 1994-96 Continuing Survey of Food Intakes and Individuals and 1994-96 Diet and Health Knowledge Survey (1997) [CD-ROM]; NTIS Accession No. PB98-500457.
65. Chiang E.P., Smith D.E., Selhub J., Dallal G., Wang Y.C., and Roubenoff R. Inflammation causes tissue-specific depletion of vitamin B-6. Arthritis Res Ther 7 (2005) R1254-R1262
66. Friso S., Jacques P.F., Wilson P.W.F., Rosenberg I.H., and Selhub J. Low circulating vitamin B-6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 103 (2001) 2788-2791
67. Chiang E.P.I., Selhub J., Bagley P.J., Dallal G., and Roubenoff R. Pyridoxine supplementation corrects vitamin B-6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther 7 (2005) R1404-R1411
68. Friso S., Girelli D., Martinelli N., Olivieri O., Lotto V., Bozzini C., Pizzolo F., Faccini G., Beltrame F., and Corrocher R. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 79 (2004) 992-998
69. Folsom A.R., Desvarieux M., Nieto F.J., Boland L.L., Ballantyne C.M., and Chambless L.E. B vitamin status and inflammatory markers. Atherosclerosis 169 (2003) 169-174
70. Arnalich F., Zamorano A.F., Benito-Urbina S., Gijon-Banos J., De Miguel E., Pena J.M., and Vazquez J.J. Increased apotranscobalamin II levels in rheumatoid arthritis. Br J Rheumatol 29 (1990) 171-173
71. Vreugdenhil G., Lindemans J., van Eijk H.G., and Swaak A.J.G. Elevated serum transcobalamin levels in anaemia of rheumatoid arthritis: correlation with disease activity but not with serum tumour necrosis factor alpha and interleukin 6. J Int Med 231 (1992) 547-550
72. Wickramasinghe S.N., and Fida S. Correlations between holo-transcobalamin II, holo-haptocorrin, and total B-12 in serum samples from healthy subjects and patients. J Clin Pathol 46 (1993) 537-539
73. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 285 (2001) 2486-2497